adesso Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

adesso şirketinin toplam hissedar öz sermayesi €206.6M ve toplam borcu €143.0M olup, bu da borç-öz sermaye oranını 69.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla €790.8M ve €584.3M dir. adesso 'in FAVÖK'ü €26.1M faiz karşılama oranı 2.3 dur. Şirketin €44.8M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

69.2%

Borç/özkaynak oranı

€143.02m

Borç

Faiz karşılama oranı	2.3x
Nakit	€44.77m
Eşitlik	€206.56m
Toplam yükümlülükler	€584.26m
Toplam varlıklar	€790.82m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ADN1 'nin kısa vadeli varlıkları ( €372.1M ) kısa vadeli yükümlülüklerini ( €315.0M ) aşıyor.

Uzun Vadeli Yükümlülükler: ADN1 şirketinin kısa vadeli varlıkları ( €372.1M ) uzun vadeli yükümlülüklerini ( €269.3M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ADN1 'nin net borç/öz sermaye oranı ( 47.6% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: ADN1 şirketinin borç/öz sermaye oranı son 5 yılda 62.7% seviyesinden 69.2% seviyesine yükseldi.

Borç Kapsamı: ADN1 'nin borcu işletme nakit akışı ( 94.1% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: ADN1 'in borcuna ilişkin faiz ödemeleri EBIT ( 2.3 x kapsam) tarafından iyi karşılanmıyor.

adesso Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

adesso SE to Report Q3, 2025 Results on Nov 12, 2025

Third quarter 2024 earnings released: EPS: €1.67 (vs €0.85 in 3Q 2023)

New minor risk - Share price stability

Now 24% overvalued

Second quarter 2024 earnings released: €1.02 loss per share (vs €1.18 loss in 2Q 2023)

New minor risk - Share price stability

Now 31% undervalued after recent price drop

Price target decreased by 7.4% to €162

Upcoming dividend of €0.70 per share

New major risk - Financial position

First quarter 2024 earnings released: €0.49 loss per share (vs €0.28 profit in 1Q 2023)

New major risk - Financial position

Full year 2023 earnings: EPS misses analyst expectations

Dividend increased to €0.70

adesso SE to Report Fiscal Year 2023 Results on Mar 25, 2024

adesso SE to Report Q3, 2024 Results on Nov 14, 2024

Third quarter 2023 earnings released: EPS: €0.85 (vs €2.01 in 3Q 2022)

adesso SE Announces CEO Changes

Second quarter 2023 earnings released: €1.18 loss per share (vs €0.29 loss in 2Q 2022)

Now 21% undervalued after recent price drop

adesso SE Announces Board Changes

Now 21% undervalued after recent price drop

Upcoming dividend of €0.65 per share at 0.5% yield

First quarter 2023 earnings released: EPS: €0.28 (vs €1.92 in 1Q 2022)

Now 21% undervalued after recent price drop

adesso SE (XTRA:ADN1) signed an agreement to acquire 51% stake in Wepex GmbH.

adesso SE (XTRA:ADN1) acquired WebScience Srl.

adesso SE to Report Q1, 2023 Results on May 15, 2023

Third quarter 2022 earnings released: EPS: €2.01 (vs €1.86 in 3Q 2021)

Price target decreased to €203

Price target decreased to €208

Second quarter 2022 earnings released: €0.29 loss per share (vs €1.12 profit in 2Q 2021)

adesso SE Revises Earnings Guidance for the Full Year 2022

adesso SE Revises Earnings Guidance for the Full Year 2022

adesso SE (XTRA:ADN1) acquired Quadox Ag.

adesso SE (XTRA:ADN1) acquired remaining 41% stake in com2m GmbH.

Investor sentiment deteriorated over the past week

Upcoming dividend of €0.60 per share

First quarter 2022 earnings: EPS exceeds analyst expectations

adesso SE (XTRA:ADN1) acquired Purple Scout AB from Johan Strömhage and Helena Bendz and others.

Now 23% undervalued after recent price drop

Full year 2021 earnings: EPS exceeds analyst expectations

Now 21% undervalued

adesso SE acquired additional 23.4% minority stake in Material.One AG.

adesso SE Revises Earnings Guidance for the Full Year of 2021

Third quarter 2021 earnings released: EPS €1.86 (vs €1.25 in 3Q 2020)

Investor sentiment improved over the past week

First half 2021 earnings released: EPS €4.90 (vs €0.89 in 1H 2020)

Price target increased to €157

Price target increased to €144

Upcoming dividend of €0.52 per share

Price target increased to €134

adesso SE Provides Earnings Guidance for the Full Year 2021

CrownPeak Technology, Inc. entered into a definitive agreement to acquire E-Spirit Ag from adesso SE (XTRA:ADN1).

adesso Subsidiary Signs Contract with Pensionskasse der Mitarbeiter der Hoechst-Gruppe to Overhaul Entire Application Environment on the Basis of In|Sure Products

New 90-day high: €114

New 90-day high: €108

adesso SE to Report Q1, 2021 Results on May 12, 2021

adesso SE (XTRA:ADN1) acquired 51% stake in LeanNet Ltd.

Market bids up stock over the past week

Market bids up stock over the past week

Price target raised to €96.00

New 90-day high: €76.20

adesso SE (XTRA:ADN1) acquired an unknown majority stake in Blue4IT, Codesquad and Bluefront from Blue Group IT B.V.

Market bids up stock over the past week

New 90-day high - €76.00

Price target raised to €85.50

First half earnings released

New 90-day high - €68.60

New 90-day high - €61.00

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin